Immunity against Hepatitis B Virus and HBV Vaccines

[1]  Thomas Berg,et al.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.

[2]  S. Sehrawat,et al.  Immunity to Infections , 2017 .

[3]  G. Missale,et al.  T cell regulation in HBV-related chronic liver disease. , 2017, Journal of hepatology.

[4]  M. Ferracin,et al.  Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B , 2017, Nature Medicine.

[5]  T. Volz,et al.  Serum HBV pgRNA as a clinical marker for cccDNA activity. , 2017, Journal of hepatology.

[6]  N. Chuaypen,et al.  Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg‐positive and HBeAg‐negative chronic hepatitis B , 2017, Journal of medical virology.

[7]  R. Mikolajczyk,et al.  Time trends of chronic HBV infection over prior decades - A global analysis. , 2017, Journal of hepatology.

[8]  N. Sakamoto,et al.  Viral life cycle of hepatitis B virus: Host factors and druggable targets , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[9]  B. McMahon,et al.  Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose. , 2016, The Journal of infectious diseases.

[10]  E. Thomas,et al.  Experimental models of hepatitis B and C — new insights and progress , 2016, Nature Reviews Gastroenterology &Hepatology.

[11]  E. Remmerswaal,et al.  Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy. , 2016, Journal of hepatology.

[12]  M. Sugiyama,et al.  Indoleamine‐2,3‐dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B , 2016, Hepatology.

[13]  Jianming Hu,et al.  Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes , 2015, Journal of Virology.

[14]  R. Sun,et al.  Kupffer Cells Support Hepatitis B Virus–Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen–TLR2 Interactions in Mice , 2015, The Journal of Immunology.

[15]  Jiyuan Zhang,et al.  Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients , 2015, Cellular and Molecular Immunology.

[16]  C. Rice,et al.  The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. , 2015, Immunity.

[17]  H. Roggendorf,et al.  Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine , 2015, Medical Microbiology and Immunology.

[18]  P. Knolle,et al.  Hepatic immune regulation and its involvement in viral hepatitis infection. , 2014, Gastroenterology.

[19]  K. Okkenhaug,et al.  IL-21 Promotes CD4 T Cell Responses by Phosphatidylinositol 3-Kinase–Dependent Upregulation of CD86 on B Cells , 2014, The Journal of Immunology.

[20]  A. Lok,et al.  Management of hepatitis B: our practice and how it relates to the guidelines. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  M. Massari,et al.  Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV. , 2012, Gastroenterology.

[22]  Wenhui Li,et al.  Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus , 2012, eLife.

[23]  P. Lampertico,et al.  IL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection , 2012, The Journal of Immunology.

[24]  P. Lampertico,et al.  Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. , 2012, Gastroenterology.

[25]  Donavan T. Cheng,et al.  Transcriptomic analysis of the woodchuck model of chronic hepatitis B , 2012, Hepatology.

[26]  Ding-Shinn Chen,et al.  High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. , 2012, Gastroenterology.

[27]  P. Pugnale,et al.  Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections. , 2011, Journal of hepatology.

[28]  A. Bertoletti,et al.  Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. , 2011, Journal of hepatology.

[29]  W. Mason,et al.  Hepatitis B Virus , 2011 .

[30]  M. Massari,et al.  Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. , 2010, Gastroenterology.

[31]  F. Zoulim,et al.  Control of hepatitis B virus replication by innate response of HepaRG cells , 2010, Hepatology.

[32]  Hildegard Büning,et al.  Not interferon, but interleukin‐6 controls early gene expression in hepatitis B virus infection , 2009, Hepatology.

[33]  Chien-Jen Chen,et al.  Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. , 2009, Journal of the National Cancer Institute.

[34]  P. Klenerman,et al.  Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. , 2009, Gastroenterology.

[35]  G. Michelone,et al.  Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. , 2009, Gastroenterology.

[36]  Y. Kamatani,et al.  A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians , 2009, Nature Genetics.

[37]  B. McMahon.  The natural history of chronic hepatitis B virus infection , 2009, Hepatology.

[38]  M. Massari,et al.  Early kinetics of innate and adaptive immune responses during hepatitis B virus infection , 2009, Gut.

[39]  N. D. Churchill,et al.  Churchill and Tomasz I. Michalak Hepadnavirus during Acute Infection with Woodchuck Responses Immediately after Invasion and with Innate and Adaptive Immune Intrahepatic Expression of Genes Affiliated , 2022 .

[40]  C. Yen,et al.  Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. , 2007, Gastroenterology.

[41]  M. Nassal,et al.  Inhibition of Alpha Interferon Signaling by Hepatitis B Virus , 2006, Journal of Virology.

[42]  C. Gibbs,et al.  Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. , 2004, Gastroenterology.

[43]  R. Kaslow,et al.  HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination , 2004, Hepatology.

[44]  R. Nieuwland,et al.  Saccharomyces cerevisiae‐derived HBsAg preparations differ in their attachment to monocytes, immune‐suppressive potential, and T‐cell immunogenicity , 2003, Journal of medical virology.

[45]  R. Purcell,et al.  CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.

[46]  F. Chisari,et al.  Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[47]  H. Chiou,et al.  Long‐term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B , 2002, Hepatology.

[48]  L. Stuyver,et al.  Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity. , 2000, Journal of hepatology.

[49]  W. Carman,et al.  The clinical significance of surface antigen variants of hepatitis B virus , 1997, Journal of viral hepatitis.

[50]  F. Chisari,et al.  Long-lasting memory T cell responses following self-limited acute hepatitis B. , 1996, The Journal of clinical investigation.